Eldepryl (selegiline) Treatment Report
Generic Name: Selegiline
What is Eldepryl?
Eldepryl® is a brand name for the drug selegiline, a Monoamine Oxidase (MAO) Type B inhibitor which slows the breakdown of levodopa. Used in combination with levodopa containing drugs such as Sinemet it can improve their efficacy.
Reasons taken & Efficacy
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Treat Parkinson's | 12 |
|
1 | ||||
| Tremors, hands | 2 | 0 | |||||
| prevention | 1 |
|
1 | ||||
| Other | 1 |
|
1 |
Mouse over the table for more information
Side Effects
Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
3 | 38% |
|
|
Doctor's advice
|
2 | 25% |
|
|
Personal research
|
1 | 13% |
|
|
Side effects too severe
|
1 | 13% |
|
|
Other
|
1 | 13% |
|
|
Course of treatment ended
|
1 | 13% |
|
Adherence, Burden & Cost See details from patient evaluations ▼
See more information, including instructions, precautions, side effects, and interactions.
Patient Evaluations
See all 3 patient evaluations
-
- cmsf
- Sex: M
- Mouth/throat: mild
- Arms: severe
- Chest: severe
- Legs: severe
- See profile
-
-
- cmsf
- since Aug 25, 2008
-
Efficacy
None
for Other
-
Side Effects
Severe
- Advice/Tips Mental changes are not always recognizable by behavioral changes. Be cautious about using any medication that does not warrant use by evident and observable... See full evaluation
See all 3 patient evaluations
Report created on November 24, 2009.